ALLO · Company research
Allogene Therapeutics, Inc. Common Stock (ALLO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Allogene Therapeutics (ALLO) Short Interest & Short Float | Updated Oct 2026 $ALLO - MarketBeat | Allogene Therapeutics (ALLO) Short Interest & Short Float | Updated Oct 2026 $ALLO MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| At $1.55 a share, TPG funds sold Allogene Therapeutics (ALLO) stock. - Stock Titan | At $1.55 a share, TPG funds sold Allogene Therapeutics (ALLO) stock. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance | Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 11, 2026 | neutral | 0 | 0.6 |
| Allogene: If MRD Holds, This Becomes A Completely Different Company - Seeking Alpha | Allogene: If MRD Holds, This Becomes A Completely Different Company Seeking Alpha | View source ↗ | Seeking Alpha | Sep 6, 2026 | neutral | 0 | 0.6 |
| Allogene (NASDAQ: ALLO) exec plans sale of 29,697 shares - Stock Titan | Allogene (NASDAQ: ALLO) exec plans sale of 29,697 shares Stock Titan | View source ↗ | Stock Titan | Aug 21, 2026 | neutral | 0 | 0.6 |
| Allogene Therapeutics, Inc. SEC Filing (Aug 21, 2026) - Stock Titan | Allogene Therapeutics, Inc. SEC Filing (Aug 21, 2026) Stock Titan | View source ↗ | Stock Titan | Aug 21, 2026 | neutral | 0 | 0.6 |
| Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance | Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 17, 2026 | neutral | 0 | 0.6 |
| $ALLO stock is up 11% today. Here's what we see in our data. - Quiver Quantitative | $ALLO stock is up 11% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 29, 2026 | neutral | 0 | 0.6 |
| ALLO Forecast — Price Target — Prediction for 2027 - TradingView | ALLO Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio - Yahoo Finance | Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio Yahoo Finance | View source ↗ | Yahoo Finance | Jun 7, 2026 | neutral | 0 | 0.6 |
| ALLO Stock Soars As ALPHA3 Trial Data Reset Expectations - Timothy Sykes | ALLO Stock Soars As ALPHA3 Trial Data Reset Expectations Timothy Sykes | View source ↗ | Timothy Sykes | Apr 16, 2026 | neutral | 0 | 0.6 |
| ALLO Stock Slides As $175M Equity Offering Hits Tape - Timothy Sykes | ALLO Stock Slides As $175M Equity Offering Hits Tape Timothy Sykes | View source ↗ | Timothy Sykes | Apr 15, 2026 | neutral | 0 | 0.6 |
| ALLO Stock Hits 2-Year Highs – Analyst Calls Allogene’s Phase 2 Trial Data To Treat Lymphoma A ‘Home Run’ - Stocktwits | ALLO Stock Hits 2-Year Highs – Analyst Calls Allogene’s Phase 2 Trial Data To Treat Lymphoma A ‘Home Run’ Stocktwits | View source ↗ | Stocktwits | Apr 13, 2026 | neutral | 0 | 0.6 |
| ALLO Stock Jumps As Pivotal ALPHA3 Trial Catalyst Nears - Timothy Sykes | ALLO Stock Jumps As Pivotal ALPHA3 Trial Catalyst Nears Timothy Sykes | View source ↗ | Timothy Sykes | Apr 13, 2026 | neutral | 0 | 0.6 |
| Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)? - Yahoo Finance | Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 12, 2026 | neutral | 0 | 0.6 |
| $ALLO stock is down 10% today. Here's what we see in our data. | ALLO Stock News - Quiver Quantitative | $ALLO stock is down 10% today. Here's what we see in our data. | ALLO Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 10, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.